300760 迈瑞医疗
2025/09 - 九个月
人民幣(K¥)
与去年同期
比较
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)
营业总收入25,833,907-12.38%36,725,75034,931,90130,365,64425,269,581
减:营业总成本17,055,866-4.54%24,096,44621,991,20519,826,76016,667,539
    其中:营业成本9,829,019-5.11%13,547,51912,513,13610,885,2898,842,715
               财务费用(293,078)60.70%(400,028)(854,912)(451,037)(85,973)
               资产减值损失(203,062)26.10%(237,841)(529,506)(71,094)(131,734)
公允价值变动收益670-99.47%126,02879,402(21,378)9,879
投资收益111,31073.33%69,390(9,841)(5,061)811
    其中:对联营企业和合营企业的投资收益14,921-204.88%(11,812)(9,817)(4,698)811
营业利润8,947,412-26.03%13,111,82413,069,85810,990,5159,065,717
利润总额8,901,612-26.13%13,019,69613,010,93010,953,5519,017,085
减:所得税费用1,087,718-19.30%1,279,7301,432,5171,342,8341,013,039
净利润7,813,894-26.99%11,739,96711,578,4139,610,7178,004,046
减:非控股权益243,849271.87%71,479(3,813)3,5432,492
股东净利润7,570,045-28.83%11,668,48711,582,2269,607,1748,001,554

市场价值指针
每股收益 (元) *6.248-28.84%9.6369.5597.9406.587
每股派息 (元) *4.070-28.72%6.2705.8004.5003.500
每股净资产 (元) *32.4125.94%29.57427.28826.37722.171
审计意见 #--标准的无保留意见标准的无保留意见标准的无保留意见标准的无保留意见
回页顶
备注: *未调整数据
#只提供简体内容